SOCS2 and breast cancer: Another report by Farabegoli et al demonstrated that SOCS2 expression was associated with high differentiation and a low proliferation rate in a group of 50 archival breast cancer samples, and was found to inversely correlate with several proliferation markers such as cyclin A and Ki-67 [30].